INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Company

COLLEGIUM PHARMACEUTICAL, INC

Filed

March 19, 2025

Period of Report

March 17, 2025

Accession Number

0001062993-25-005900